These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 31282129

  • 1. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
    Briguori C, D'Amore C, De Micco F, Signore N, Esposito G, Napolitano G, Focaccio A, REMEDIAL III Investigators.
    Catheter Cardiovasc Interv; 2020 Apr 01; 95(5):895-903. PubMed ID: 31282129
    [Abstract] [Full Text] [Related]

  • 2. Left Ventricular End-Diastolic Pressure Versus Urine Flow Rate-Guided Hydration in Preventing Contrast-Associated Acute Kidney Injury.
    Briguori C, D'Amore C, De Micco F, Signore N, Esposito G, Visconti G, Airoldi F, Signoriello G, Focaccio A.
    JACC Cardiovasc Interv; 2020 Sep 14; 13(17):2065-2074. PubMed ID: 32912462
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial.
    Marashizadeh A, Sanati HR, Sadeghipour P, Peighambari MM, Moosavi J, Shafe O, Firouzi A, Zahedmehr A, Maadani M, Shakerian F, Kiani R, Mohebbi B, Alemzadeh-Ansari MJ, Tahvili R, Naghavi B.
    Int Urol Nephrol; 2019 Oct 14; 51(10):1815-1822. PubMed ID: 31332700
    [Abstract] [Full Text] [Related]

  • 4. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C, Visconti G, Ricciardelli B, Condorelli G, REMEDIAL II Investigators.
    EuroIntervention; 2011 Apr 14; 6(9):1117-22, 7. PubMed ID: 21518686
    [Abstract] [Full Text] [Related]

  • 5. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM, Golia B, Ricciardelli B, Condorelli G, REMEDIAL II Investigators.
    Circulation; 2011 Sep 13; 124(11):1260-9. PubMed ID: 21844075
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
    Barbanti M, Gulino S, Capranzano P, Immè S, Sgroi C, Tamburino C, Ohno Y, Attizzani GF, Patanè M, Sicuso R, Pilato G, Di Landro A, Todaro D, Di Simone E, Picci A, Giannetto G, Costa G, Deste W, Giannazzo D, Grasso C, Capodanno D, Tamburino C.
    JACC Cardiovasc Interv; 2015 Oct 13; 8(12):1595-604. PubMed ID: 26386766
    [Abstract] [Full Text] [Related]

  • 11. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
    Brar SS, Aharonian V, Mansukhani P, Moore N, Shen AY, Jorgensen M, Dua A, Short L, Kane K.
    Lancet; 2014 May 24; 383(9931):1814-23. PubMed ID: 24856027
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tailored Versus Standard Hydration to Prevent Acute Kidney Injury After Percutaneous Coronary Intervention: Network Meta-Analysis.
    Moroni F, Baldetti L, Kabali C, Briguori C, Maioli M, Toso A, Brilakis ES, Gurm HS, Bagur R, Azzalini L.
    J Am Heart Assoc; 2021 Jul 06; 10(13):e021342. PubMed ID: 34169747
    [Abstract] [Full Text] [Related]

  • 14. RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY study.
    Katoh H, Nozue T, Horie K, Sozu T, Inoue N, Michishita I.
    Cardiovasc Interv Ther; 2019 Apr 06; 34(2):105-112. PubMed ID: 29730853
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI.
    Mauler-Wittwer S, Sievert H, Ioppolo AM, Mahfoud F, Carrié D, Lipiecki J, Nickenig G, Fajadet J, Eckert S, Morice MC, Garot P.
    JACC Cardiovasc Interv; 2022 Aug 22; 15(16):1639-1648. PubMed ID: 35981838
    [Abstract] [Full Text] [Related]

  • 20. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R, Faggioni M, Chandrasekhar J, Angiolillo DJ, Bertolet B, Jobe RL, Al-Joundi B, Brar S, Dangas G, Batchelor W, Prasad A, Gurm HS, Tumlin J, Stone GW.
    JACC Cardiovasc Interv; 2018 Aug 27; 11(16):1601-1610. PubMed ID: 30139467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.